AKT1 and chronic obstructive pulmonary disease: As a proof-of-concept, the GRS associated with lower FEV1/FVC specific to PI3K–Akt signaling was associated with increased risk of COPD but a lower risk of diabetes; PI3K inhibition impairs glucose uptake in muscle and increases hepatic gluconeogenesis, contributing to glucose intolerance and diabetes41.